We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

28 hedge funds and large institutions have $111M invested in Milestone Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $416K

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.52% less ownership

Funds ownership: 68.03% → 67.5% (-0.52%)

6% less capital invested

Capital invested by funds: $117M → $111M (-$6.63M)

18% less funds holding

Funds holding: 34 → 28 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
8
Calls
$2.19M
Puts
$416K
Net Calls
+$1.77M
Net Calls Change
-$574K

Top Buyers

1
PVI
Pura Vida Investments
New York
+$1.33M
2
IC
Ikarian Capital
Texas
+$816K
3
Barclays
Barclays
United Kingdom
+$267K
4
Morgan Stanley
Morgan Stanley
New York
+$194K
5
BFM
Boothbay Fund Management
New York
+$93.2K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.55M
2
Renaissance Technologies
Renaissance Technologies
New York
-$617K
3
JGC
J. Goldman & Co
New York
-$581K
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$290K
5
Two Sigma Investments
Two Sigma Investments
New York
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$23.7M – – –
O
2
OrbiMed
New York
$14.2M – – –
BC
3
Boxer Capital
California
$14.1M – – –
NHAS
4
Novo Holdings A/S
Denmark
$13.9M – – –
RCM
5
RA Capital Management
Massachusetts
$12.4M – – –
IC
6
Ikarian Capital
Texas
$10.9M +$816K +143,855 +8%
Morgan Stanley
7
Morgan Stanley
New York
$4.87M +$194K +34,157 +4%
SCM
8
Suvretta Capital Management
New York
$4.68M – – –
Millennium Management
9
Millennium Management
New York
$3.95M +$4.72K +833 +0.1%
PVI
10
Pura Vida Investments
New York
$3.86M +$1.33M +234,905 +50%
BFM
11
Boothbay Fund Management
New York
$1.24M +$93.2K +16,426 +8%
Barclays
12
Barclays
United Kingdom
$1.12M +$267K +47,025 +30%
Renaissance Technologies
13
Renaissance Technologies
New York
$592K -$617K -108,846 -50%
SFI
14
Susquehanna Fundamental Investments
Pennsylvania
$283K -$51.8K -9,135 -15%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$260K +$50.4K +8,884 +23%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$196K -$128K -22,500 -39%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$114K – – –
State Street
18
State Street
Massachusetts
$91K -$2.21K -390 -2%
Two Sigma Investments
19
Two Sigma Investments
New York
$89K -$219K -38,578 -70%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$67K +$68.5K +12,069 New
Goldman Sachs
21
Goldman Sachs
New York
$66K – – –
FDCDDQ
22
Federation des caisses Desjardins du Quebec
Quebec, Canada
$57.8K -$567 -100 -0.9%
TRCT
23
Tower Research Capital (TRC)
New York
$9K +$8.88K +1,566 New
Osaic Holdings
24
Osaic Holdings
Arizona
$8K +$4.94K +871 +145%
UBS Group
25
UBS Group
Switzerland
$3K -$73.8K -13,016 -96%
1
2

MIST Hedge Fund Activity: Q2 2021 in Review

28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q2 2021, worth a combined $111M — down 5.6% from $117M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MIST and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 8 added.

The largest buyer was Pura Vida Investments, adding an estimated $1.33M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $1.55M sold.

  • 28 institutional investors held Milestone Pharmaceuticals (MIST) as of Q2 2021, down from 34 in Q1 2021.
  • Funds reported $111M of Milestone Pharmaceuticals stock for Q2 2021, down 5.6% quarter-over-quarter.
  • 2 funds opened new Milestone Pharmaceuticals positions in Q2 2021 and 8 closed out, a net change of -6 holders.
  • The largest Milestone Pharmaceuticals buyer in Q2 2021 was Pura Vida Investments, an estimated $1.33M added.
  • The largest Milestone Pharmaceuticals seller in Q2 2021 was T. Rowe Price Associates, an estimated $1.55M sold.

Based on aggregated 13F filings for Q2 2021.